TAILIEUCHUNG - The non-fatal burden of cancer in Belgium, 2004–2019: A nationwide registry-based study

The importance of assessing and monitoring the health status of a population has grown in the last decades. Consistent and high quality data on the morbidity and mortality impact of a disease represent the key element for this assessment. | Gorasso et al. BMC Cancer 2022 22 58 https s12885-021-09109-4 RESEARCH Open Access The non-fatal burden of cancer in Belgium 2004 2019 a nationwide registry-based study Vanessa Gorasso1 2 Geert Silversmit3 Marc Arbyn1 4 Astrid Cornez1 Robby De Pauw1 5 Delphine De Smedt2 Ian Grant6 Grant M. A. Wyper6 Brecht Devleesschauwer1 7 and Niko Speybroeck8 Abstract Background The importance of assessing and monitoring the health status of a population has grown in the last decades. Consistent and high quality data on the morbidity and mortality impact of a disease represent the key element for this assessment. Being increasingly used in global and national burden of diseases BoD studies the Disability-Adjusted Life Year DALY is an indicator that combines healthy life years lost due to living with disease Years Lived with Disability YLD and due to dying prematurely Years of Life Lost YLL . As a step towards a compre- hensive national burden of disease study this study aims to estimate the non-fatal burden of cancer in Belgium using national data. Methods We estimated the Belgian cancer burden from 2004 to 2019 in terms of YLD using national population- based cancer registry data and international disease models. We developed a microsimulation model to translate inci- dence- into prevalence-based estimates and used expert elicitation to integrate the long-term impact of increased disability due to surgical treatment. Results The age-standardized non-fatal burden of cancer increased from 2004 to 2019 by 6 and 3 respectively for incidence- and prevalence-based YLDs. In 2019 in Belgium breast cancer had the highest morbidity impact among women followed by colorectal and non-melanoma skin cancer. Among men prostate cancer had the highest mor- bidity impact followed by colorectal and non-melanoma skin cancer. Between 2004 and 2019 non-melanoma skin cancer significantly increased for both sexes in terms of age-standardized incidence-based YLD per 100 000 from 49 to .

• Y khoa - Dược
• BMC Cancer
• Burden of disease
• Years lived with disability
• Public health policies
• Skin cancer
• Non melanoma skin cancer
• Cancer patient pathways
• Colorectal cancer
• Lung cancer
• Breast cancer
• Prostate cancer
• Ovarian cancer
• Cancer detection
• Ovarian cancer symptoms
• Ovarian cancer signs
• Ovarian cancer tests
• Cancer biomarkers
• Pediatric cancer
• Familial cancer predisposition
• Hereditary cancer syndrome
• Genetic cancer susceptibility
• Advanced cancer
• Biliary tract cancer
• Multimodal intervention
• Pancreatic cancer
• Physical activity
• Breast cancer screening
• Familial breast cancer
• Young breast cancer survivors
• High risk relatives
• Randomized trial
• Childhood cancer
• Childhood cancer survivor
• Thyroid cancer screening
• Secondary cancer
• Cancer screening
• Community awareness
• Cancer education
• Cervical cancer
• Prior cancer
• Cancer survivors
• Cancer registry
• Second cancer
• Surgical oncology
• Cancer imaging
• Radiation oncologists
• Medical oncologists
• Oesophagogastric cancer
• Liver cancer
• Hepatobiliary cancer
• Multidisciplinary rehabilitation
• EGFR mutation
• Family history of cancer
• Inherited susceptibility
• Cancer predisposition genes
• Lung cancer aetiology
• Cancer stem cells
• Oct4 overexpressing lung cancer
• Human lung cancer xenograft model
• Disease free survivals
• Cancer hallmarks
• Cancer genesis
• Defiant disease
• Mutational signature
• Cancer diagnosis
• Cancer genomics
• Molecular medicine
• Whole genome sequencing
• Cancer susceptibility gene
• Breast cancer prognosis
• Next generation sequencing
• Quality of care
• Quality indicators
• Shifting cancer care
• German cancer society
• Colorectal cancer screening
• Stomach cancer screening
• Lung cancer survivor
• Physician recommendation
• Total number of lymph nodes
• Lymph node ratio
• Left colon cancer
• Right colon cancer
• Overall survival
• Cumulative incidence
• Esophageal cancer
• Head and neck cancer
• Metachronous cancer
• Young onset
• Reproductive cancer
• Risk factor
• Early detection of cancer
• Gastric cancer incidence
• Population based specialized registry
• Gastric cancer survival
• Gastric cancer clinical characteristics
• Gastric cancer pathological characteristics
• Lung Cancer Screening
• Racial disparities
• Lung Cancer diagnosis
• Screening adherence
• Second primary colorectal cancer
• Standardized incidence ratio
• Left sided colon cancer
• Right sided colon cancer
• Quality of cancer care
• Population based study